Dougherty & Co Comments on Semler Scientific Inc’s Q3 2019 Earnings (OTCMKTS:SMLR)

Semler Scientific Inc (OTCMKTS:SMLR) – Equities researchers at Dougherty & Co issued their Q3 2019 earnings per share estimates for Semler Scientific in a report issued on Monday, July 29th. Dougherty & Co analyst K. Bauser anticipates that the medical equipment provider will post earnings of $0.28 per share for the quarter. Dougherty & Co also issued estimates for Semler Scientific’s FY2019 earnings at $1.12 EPS and FY2020 earnings at $1.22 EPS.

Semler Scientific (OTCMKTS:SMLR) last released its earnings results on Friday, July 26th. The medical equipment provider reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.10. Semler Scientific had a return on equity of 173.55% and a net margin of 27.91%. The company had revenue of $7.95 million for the quarter, compared to the consensus estimate of $6.72 million.

Separately, ValuEngine cut Semler Scientific from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 2nd.

Shares of Semler Scientific stock opened at $52.07 on Tuesday. The business’s 50 day moving average is $45.57. The firm has a market cap of $336.37 million, a PE ratio of 78.89, a price-to-earnings-growth ratio of 2.72 and a beta of 0.41. Semler Scientific has a twelve month low of $18.00 and a twelve month high of $54.50.

In other news, VP Daniel E. Conger sold 4,500 shares of the firm’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $41.13, for a total transaction of $185,085.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Daniel E. Conger sold 2,500 shares of the firm’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $44.52, for a total value of $111,300.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 96,285 shares of company stock worth $4,224,925. 13.90% of the stock is owned by insiders.

Semler Scientific Company Profile

Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Article: Calculate Your Return on Investment (ROI)

Earnings History and Estimates for Semler Scientific (OTCMKTS:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.